<VariationArchive VariationID="3241015" VariationName="NM_024529.5(CDC73):c.520_523del (p.Ser174fs)" VariationType="Deletion" Accession="VCV003241015" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2024-06-17" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3399997" VariationID="3241015">
      <GeneList>
        <Gene Symbol="CDC73" FullName="cell division cycle 73" GeneID="79577" HGNC_ID="HGNC:16783" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193122031" stop="193254815" display_start="193122031" display_stop="193254815" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="193091087" stop="193223944" display_start="193091087" display_stop="193223944" Strand="+" />
          </Location>
          <OMIM>607393</OMIM>
          <Haploinsufficiency last_evaluated="2022-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDC73">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-04-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CDC73">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_024529.5(CDC73):c.520_523del (p.Ser174fs)</Name>
      <CanonicalSPDI>NC_000001.11:193141854:TGTCTG:TG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="193141855" stop="193141858" display_start="193141855" display_stop="193141858" variantLength="4" positionVCF="193141854" referenceAlleleVCF="TTGTC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="193110985" stop="193110988" display_start="193110985" display_stop="193110988" variantLength="4" positionVCF="193110984" referenceAlleleVCF="TTGTC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>S174fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.193110987_193110990del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.193110987_193110990del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.193141857_193141860del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.193141857_193141860del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012691.1" sequenceAccession="NG_012691" sequenceVersion="1" change="g.24900_24903del">
            <Expression>NG_012691.1:g.24900_24903del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024529.5" sequenceAccession="NM_024529" sequenceVersion="5" change="c.520_523del" MANESelect="true">
            <Expression>NM_024529.5:c.520_523del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_078805.3" sequenceAccession="NP_078805" sequenceVersion="3" change="p.Ser174fs">
            <Expression>NP_078805.3:p.Ser174fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_507" sequenceAccession="LRG_507">
            <Expression>LRG_507:g.24900_24903del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_507t1" sequenceAccession="LRG_507t1">
            <Expression>LRG_507t1:c.520_523del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_507p1" sequenceAccession="LRG_507p1" change="p.Ser174Lysfs">
            <Expression>LRG_507p1:p.Ser174Lysfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024529.5(CDC73):c.520_523del (p.Ser174fs) AND Hyperparathyroidism 1" Accession="RCV004575501" Version="1">
        <ClassifiedConditionList TraitSetID="835">
          <ClassifiedCondition DB="MedGen" ID="C1840402">Hyperparathyroidism 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-20" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-17" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="835" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1734" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HYPERPARATHYROIDISM, FAMILIAL ISOLATED PRIMARY</ElementValue>
                <XRef Type="MIM" ID="145000" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613733.0031" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hyperparathyroidism 1</ElementValue>
                <XRef ID="319534" DB="GeneTests" />
                <XRef ID="Hyperparathyroidism+1/8597" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007767" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FIHP</ElementValue>
                <XRef Type="MIM" ID="145000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">HRPT1</ElementValue>
                <XRef Type="MIM" ID="145000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">CDC73-Related Disorders</Attribute>
                <XRef ID="226120" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18253" />
                <XRef ID="18253" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of CDC73-related disorders includes the following phenotypes: Hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Primary hyperparathyroidism, the main finding of HPT-JT syndrome, occurs in up to 95% of affected individuals; onset is typically in late adolescence or early adulthood. HPT-JT-associated primary hyperparathyroidism is usually caused by a single parathyroid adenoma. In approximately 10%-15% of individuals, primary hyperparathyroidism is caused by parathyroid carcinoma. Ossifying fibromas of the mandible or maxilla, also known as cementifying fibromas and cemento-ossifying fibromas, occur in 30%-40% of individuals with HPT-JT syndrome. Although benign, these tumors can be locally aggressive and may continue to enlarge if not treated. Approximately 20% of individuals with HPT-JT syndrome have kidney lesions, most commonly cysts; renal hamartomas and (more rarely) Wilms tumor have also been reported. Benign and malignant uterine tumors appear to be common in women with HPT-JT syndrome. Parathyroid carcinoma. Most parathyroid carcinomas are functional, resulting in hyperparathyroidism and a high serum calcium level; however, nonfunctioning parathyroid carcinomas are also rarely described in individuals with a CDC73-related disorder. A germline CDC73 pathogenic variant has been identified in 20%-29% of individuals with apparently sporadic parathyroid carcinoma. Familial isolated hyperparathyroidism (FIHP). FIHP is characterized by primary hyperparathyroidism without other associated syndromic features. Individuals with CDC73-related FIHP tend to have a more severe clinical presentation and younger age of onset than individuals with FIHP in whom a CDC73 pathogenic variant has not been identified.</Attribute>
                <XRef ID="NBK3789" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301744</ID>
                <ID Source="BookShelf">NBK3789</ID>
              </Citation>
              <XRef ID="99879" DB="Orphanet" />
              <XRef ID="C1840402" DB="MedGen" />
              <XRef ID="MONDO:0007767" DB="MONDO" />
              <XRef Type="MIM" ID="145000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9816991" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_024529.5:c.520_523del|OMIM:145000" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005060029" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024529.5:c.520_523del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="145000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9816991" TraitType="Disease" MappingType="XRef" MappingValue="145000" MappingRef="OMIM">
        <MedGen CUI="C1840402" Name="Hyperparathyroidism 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

